MedPath

Exercise intervention trial for women with breast cancer related lymphoedema

Not Applicable
Completed
Conditions
ymphoedema secondary to breast cancer
Lymphoedema secondary to breast cancer
Cancer - Breast
Registration Number
ACTRN12610000788077
Lead Sponsor
Edith Cowan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
60
Inclusion Criteria

Clinical diagnosis of breast cancer related lymphoedema defined as at least a 10% inter-limb discrepancy in volume or circumference at the point of greatest visible difference.

Exclusion Criteria

Any musculo-skeletal, cardiovascular or neurological disorder that could place the participant at risk of injury or illness resulting from the exercise.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ymphoedema Status and Associated Symptoms. Lymphoedema status (i.e. the amount of swelling in the upper extremity) will be assessed using standard objective measures including bioimpedance spectroscopy, arm circumference measurements and dual energy x-ray absorptiometry. Lymphoedema associated symptoms will be assessed using a modification of the Brief Pain Inventory.[Baseline and at 12 weeks (post-intervention)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath